AC Immune SA (ACIU)
2.39
-0.05
(-2.05%)
USD |
NASDAQ |
May 03, 16:00
2.39
0.00 (0.00%)
After-Hours: 20:00
AC Immune Shares Outstanding: 98.90M for March 14, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 14, 2024 | 98.90M |
March 13, 2024 | 99.20M |
March 01, 2024 | 99.20M |
December 31, 2023 | 99.20M |
December 19, 2023 | 98.80M |
December 15, 2023 | 84.50M |
September 30, 2023 | 84.45M |
June 26, 2023 | 83.53M |
March 01, 2023 | 83.62M |
December 31, 2022 | 83.62M |
June 24, 2022 | 83.41M |
May 19, 2022 | 83.55M |
March 01, 2022 | 83.48M |
December 31, 2021 | 83.48M |
August 04, 2021 | 72.66M |
April 28, 2021 | 72.65M |
April 27, 2021 | 72.65M |
March 31, 2021 | 72.65M |
March 22, 2021 | 72.65M |
March 01, 2021 | 72.70M |
December 31, 2020 | 71.94M |
October 23, 2020 | 71.74M |
Date | Value |
---|---|
June 30, 2020 | 71.74M |
March 01, 2020 | 71.86M |
December 31, 2019 | 71.86M |
November 13, 2019 | 71.66M |
May 15, 2019 | 67.36M |
March 01, 2019 | 67.56M |
December 31, 2018 | 67.56M |
August 24, 2018 | 67.36M |
August 08, 2018 | 67.36M |
July 31, 2018 | 67.40M |
July 23, 2018 | 65.90M |
May 22, 2018 | 57.40M |
May 01, 2018 | 57.39M |
April 27, 2018 | 57.36M |
March 31, 2018 | 57.36M |
March 01, 2018 | 57.36M |
December 31, 2017 | 57.36M |
May 11, 2017 | 56.92M |
March 01, 2017 | 56.92M |
December 31, 2016 | 56.77M |
September 23, 2016 | 55.40M |
September 21, 2016 | 55.40M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
67.36M
Minimum
May 15 2019
99.20M
Maximum
Dec 31 2023
80.85M
Average
83.41M
Median
Jun 24 2022
Shares Outstanding Benchmarks
CRISPR Therapeutics AG | 84.88M |
Addex Therapeutics Ltd | 1.069M |
NLS Pharmaceutics Ltd | 43.32M |
Molecular Partners AG | 32.85M |
MoonLake Immunotherapeutics | 62.87M |